113 related articles for article (PubMed ID: 32582995)
1. Identification of a multidimensional transcriptome signature predicting tumor regrowth of clinically non‑functioning pituitary adenoma.
Cheng S; Guo J; Zhang Y; Li Z; Li C
Int J Oncol; 2020 Sep; 57(3):804-812. PubMed ID: 32582995
[TBL] [Abstract][Full Text] [Related]
2. A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.
Guo J; Wang Z; Miao Y; Shen Y; Li M; Gong L; Wang H; He Y; Gao H; Liu Q; Li C; Zhang Y
Oncol Rep; 2019 Jan; 41(1):113-124. PubMed ID: 30542712
[TBL] [Abstract][Full Text] [Related]
3. A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas.
Cheng S; Guo J; Wang D; Fang Q; Liu Y; Xie W; Zhang Y; Li C
Front Genet; 2021; 12():754503. PubMed ID: 34745223
[TBL] [Abstract][Full Text] [Related]
4. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.
Cheng S; Li C; Xie W; Miao Y; Guo J; Wang J; Zhang Y
Aging (Albany NY); 2020 Feb; 12(3):2408-2427. PubMed ID: 32015217
[TBL] [Abstract][Full Text] [Related]
6. Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.
Cheng S; Wu J; Li C; Li Y; Liu C; Li G; Li W; Hu S; Ying X; Zhang Y
J Transl Med; 2019 May; 17(1):164. PubMed ID: 31109334
[TBL] [Abstract][Full Text] [Related]
7. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
8. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
[TBL] [Abstract][Full Text] [Related]
9. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
10. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
12. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
15. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract][Full Text] [Related]
18. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
19. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.
Guo W; Wang Q; Zhan Y; Chen X; Yu Q; Zhang J; Wang Y; Xu XJ; Zhu L
Sci Rep; 2016 Jun; 6():27931. PubMed ID: 27338266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
